Basic Information
Arpida AG is a biopharmaceutical company focused on the discovery and development of new drugs to address the growing problem of microbial resistance. The most advanced compounds include antibacterial agents under regulatory review and antifungal agents in Phase III.
Arpida, Inc.
Switzerland
unclear
January 01, 1997
--
--